PracticeConsultingThreat of qualification lifted.

Threat of qualification lifted.

The threat of health authorities’ accounts being qualified as a result of the generic drugs crisis seems to have been averted, Accountancy Age understands. The threat of qualification, revealed in Accountancy Age in October, arose because severe delays in processing prescriptions at the Prescription Pricing Authority means that health authorities will not have a full year’s figures for prescribing expenditure when they close their accounts in May. Two possible solutions have been investigated. Either the accounts could be delayed, although this runs into problems with the government’s timetable for the introduction of resource accounting, or accounts could be closed with an agreed level of estimated figures for drug costs. Following negotiations between the NHS Executive and the Audit Commission in January. It is now understood that the commission is happy in theory with a degree of estimation, although it wants to test the robustness of the Executive’s prediction model over the next couple of months. And officially it is insisting that decisions over the acceptability of estimated figures will be taken by auditors locally. The problems at the PPA have been caused by an explosion in what are known as category D drugs. A drug gets classified as category D when there is a problem with availability forcing pharmacists to dispense often more expensive alternatives. It takes staff at the PPA up to four times longer to process a category D prescription than it does a non-category D prescription. Normally just one per cent of prescriptions fall into this category, but the PPA says in its latest processing month nearly one in five prescriptions was category D. The latest information from the PPA is that prescribing data for October 1999 will not be with health authorities until at least the middle of February, about ten weeks later than under normal circumstances. Although health authorities should close accounts in May, the final deadline for including real prescribing data is being seen as 31 July when accounts have to be signed off by auditors. By that stage the Executive believes figures for only one or two months will have to be estimated.

Related Articles

5 tips for SMEs to protect cash flow

Accounting Software 5 tips for SMEs to protect cash flow

5m Alia Shoaib, Reporter
Tyrie on Finance Bill 2017: ‘Making Tax Policy Better’

Consulting Tyrie on Finance Bill 2017: ‘Making Tax Policy Better’

11m Stephanie Wix, Writer
Managing partner Q&A - the year ahead: Richard Toone, CVR Global

Accounting Firms Managing partner Q&A - the year ahead: Richard Toone, CVR Global

12m Kevin Reed, Writer
Deloitte 'self-imposes exile' on government contracts to defuse PM row

Accounting Firms Deloitte 'self-imposes exile' on government contracts to defuse PM row

12m Kevin Reed, Writer
Managing partner Q&A - the year ahead: Julie Adams, Menzies

Accounting Firms Managing partner Q&A - the year ahead: Julie Adams, Menzies

12m Kevin Reed, Writer
Friday Afternoon Live: Deloitte's tech thing; PAC wants HMRC 'contingencies'; and Sports Direct

Business Regulation Friday Afternoon Live: Deloitte's tech thing; PAC wants HMRC 'contingencies'; and Sports Direct

1y Kevin Reed, Writer
Friday Afternoon Live: HMRC complaints rise; Deloitte scoops big audits; and corporate reporting woes

Audit Friday Afternoon Live: HMRC complaints rise; Deloitte scoops big audits; and corporate reporting woes

1y Kevin Reed, Writer
New head of equity capital markets for KPMG

Accounting Firms New head of equity capital markets for KPMG

1y Stephanie Wix, Writer